The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viral Inactivation Market Research Report 2024
Synopsis
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The global Viral Inactivation market was valued at US$ 499.9 million in 2023 and is anticipated to reach US$ 989.3 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
This report aims to provide a comprehensive presentation of the global market for Viral Inactivation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Inactivation.
Report Scope
The Viral Inactivation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Inactivation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Inactivation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Segment by Type
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Segment by Application
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Inactivation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The global Viral Inactivation market was valued at US$ 499.9 million in 2023 and is anticipated to reach US$ 989.3 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
This report aims to provide a comprehensive presentation of the global market for Viral Inactivation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Inactivation.
Report Scope
The Viral Inactivation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Inactivation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Inactivation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Segment by Type
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Segment by Application
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Inactivation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Inactivation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits and Reagents
1.2.3 Services
1.2.4 Viral Inactivation Systems and Accessories
1.3 Market by Application
1.3.1 Global Viral Inactivation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2019-2030)
2.2 Viral Inactivation Growth Trends by Region
2.2.1 Global Viral Inactivation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Inactivation Historic Market Size by Region (2019-2024)
2.2.3 Viral Inactivation Forecasted Market Size by Region (2025-2030)
2.3 Viral Inactivation Market Dynamics
2.3.1 Viral Inactivation Industry Trends
2.3.2 Viral Inactivation Market Drivers
2.3.3 Viral Inactivation Market Challenges
2.3.4 Viral Inactivation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Inactivation Players by Revenue
3.1.1 Global Top Viral Inactivation Players by Revenue (2019-2024)
3.1.2 Global Viral Inactivation Revenue Market Share by Players (2019-2024)
3.2 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Inactivation Revenue
3.4 Global Viral Inactivation Market Concentration Ratio
3.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2023
3.5 Viral Inactivation Key Players Head office and Area Served
3.6 Key Players Viral Inactivation Product Solution and Service
3.7 Date of Enter into Viral Inactivation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Inactivation Breakdown Data by Type
4.1 Global Viral Inactivation Historic Market Size by Type (2019-2024)
4.2 Global Viral Inactivation Forecasted Market Size by Type (2025-2030)
5 Viral Inactivation Breakdown Data by Application
5.1 Global Viral Inactivation Historic Market Size by Application (2019-2024)
5.2 Global Viral Inactivation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Inactivation Market Size (2019-2030)
6.2 North America Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Inactivation Market Size by Country (2019-2024)
6.4 North America Viral Inactivation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Inactivation Market Size (2019-2030)
7.2 Europe Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Inactivation Market Size by Country (2019-2024)
7.4 Europe Viral Inactivation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Inactivation Market Size (2019-2030)
8.2 Asia-Pacific Viral Inactivation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Inactivation Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Inactivation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Inactivation Market Size (2019-2030)
9.2 Latin America Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Inactivation Market Size by Country (2019-2024)
9.4 Latin America Viral Inactivation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Inactivation Market Size (2019-2030)
10.2 Middle East & Africa Viral Inactivation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Inactivation Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Inactivation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Viral Inactivation Introduction
11.1.4 Danaher Revenue in Viral Inactivation Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Viral Inactivation Introduction
11.2.4 Merck Revenue in Viral Inactivation Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Parker Hannifin
11.3.1 Parker Hannifin Company Detail
11.3.2 Parker Hannifin Business Overview
11.3.3 Parker Hannifin Viral Inactivation Introduction
11.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2019-2024)
11.3.5 Parker Hannifin Recent Development
11.4 Sartorius
11.4.1 Sartorius Company Detail
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Viral Inactivation Introduction
11.4.4 Sartorius Revenue in Viral Inactivation Business (2019-2024)
11.4.5 Sartorius Recent Development
11.5 SGS
11.5.1 SGS Company Detail
11.5.2 SGS Business Overview
11.5.3 SGS Viral Inactivation Introduction
11.5.4 SGS Revenue in Viral Inactivation Business (2019-2024)
11.5.5 SGS Recent Development
11.6 Charles River Laboratories International
11.6.1 Charles River Laboratories International Company Detail
11.6.2 Charles River Laboratories International Business Overview
11.6.3 Charles River Laboratories International Viral Inactivation Introduction
11.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2019-2024)
11.6.5 Charles River Laboratories International Recent Development
11.7 Clean Cells
11.7.1 Clean Cells Company Detail
11.7.2 Clean Cells Business Overview
11.7.3 Clean Cells Viral Inactivation Introduction
11.7.4 Clean Cells Revenue in Viral Inactivation Business (2019-2024)
11.7.5 Clean Cells Recent Development
11.8 Rad Source Technologies
11.8.1 Rad Source Technologies Company Detail
11.8.2 Rad Source Technologies Business Overview
11.8.3 Rad Source Technologies Viral Inactivation Introduction
11.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2019-2024)
11.8.5 Rad Source Technologies Recent Development
11.9 Texcell
11.9.1 Texcell Company Detail
11.9.2 Texcell Business Overview
11.9.3 Texcell Viral Inactivation Introduction
11.9.4 Texcell Revenue in Viral Inactivation Business (2019-2024)
11.9.5 Texcell Recent Development
11.10 Viral Inactivated Plasma Systems
11.10.1 Viral Inactivated Plasma Systems Company Detail
11.10.2 Viral Inactivated Plasma Systems Business Overview
11.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
11.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2019-2024)
11.10.5 Viral Inactivated Plasma Systems Recent Development
11.11 Wuxi Pharmatech (Cayman)
11.11.1 Wuxi Pharmatech (Cayman) Company Detail
11.11.2 Wuxi Pharmatech (Cayman) Business Overview
11.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
11.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2019-2024)
11.11.5 Wuxi Pharmatech (Cayman) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
